1,620
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

, , , , , , , , , , & show all
Article: 2268764 | Received 04 Oct 2023, Accepted 04 Oct 2023, Published online: 11 Oct 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.